These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 19875977)
1. Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion. Han SJ; Ahn BJ; Waldron JS; Yang I; Fang S; Crane CA; Pieper RO; Parsa AT Neuroreport; 2009 Dec; 20(18):1597-602. PubMed ID: 19875977 [TBL] [Abstract][Full Text] [Related]
2. Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma. Waldron JS; Yang I; Han S; Tihan T; Sughrue ME; Mills SA; Pieper RO; Parsa AT J Clin Neurosci; 2010 Dec; 17(12):1543-7. PubMed ID: 20822910 [TBL] [Abstract][Full Text] [Related]
3. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Parsa AT; Waldron JS; Panner A; Crane CA; Parney IF; Barry JJ; Cachola KE; Murray JC; Tihan T; Jensen MC; Mischel PS; Stokoe D; Pieper RO Nat Med; 2007 Jan; 13(1):84-8. PubMed ID: 17159987 [TBL] [Abstract][Full Text] [Related]
4. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis. Zhang R; Banik NL; Ray SK Neurochem Res; 2007 Dec; 32(12):2194-202. PubMed ID: 17616812 [TBL] [Abstract][Full Text] [Related]
5. PTEN/PI3K/mTOR/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer. Zhang Y; Zhang J; Xu K; Xiao Z; Sun J; Xu J; Wang J; Tang Q Hepatogastroenterology; 2013 Oct; 60(127):1766-72. PubMed ID: 24624456 [TBL] [Abstract][Full Text] [Related]
6. Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities. Filbin MG; Dabral SK; Pazyra-Murphy MF; Ramkissoon S; Kung AL; Pak E; Chung J; Theisen MA; Sun Y; Franchetti Y; Sun Y; Shulman DS; Redjal N; Tabak B; Beroukhim R; Wang Q; Zhao J; Dorsch M; Buonamici S; Ligon KL; Kelleher JF; Segal RA Nat Med; 2013 Nov; 19(11):1518-23. PubMed ID: 24076665 [TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis. Zhang R; Banik NL; Ray SK Brain Res; 2008 Nov; 1239():216-25. PubMed ID: 18804099 [TBL] [Abstract][Full Text] [Related]
8. Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo. Schreiner B; Wischhusen J; Mitsdoerffer M; Schneider D; Bornemann A; Melms A; Tolosa E; Weller M; Wiendl H Glia; 2003 Dec; 44(3):296-301. PubMed ID: 14603470 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. Cloughesy TF; Yoshimoto K; Nghiemphu P; Brown K; Dang J; Zhu S; Hsueh T; Chen Y; Wang W; Youngkin D; Liau L; Martin N; Becker D; Bergsneider M; Lai A; Green R; Oglesby T; Koleto M; Trent J; Horvath S; Mischel PS; Mellinghoff IK; Sawyers CL PLoS Med; 2008 Jan; 5(1):e8. PubMed ID: 18215105 [TBL] [Abstract][Full Text] [Related]
10. PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer. Crane CA; Panner A; Murray JC; Wilson SP; Xu H; Chen L; Simko JP; Waldman FM; Pieper RO; Parsa AT Oncogene; 2009 Jan; 28(2):306-12. PubMed ID: 18850006 [TBL] [Abstract][Full Text] [Related]
11. B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells. Yao Y; Tao R; Wang X; Wang Y; Mao Y; Zhou LF Neuro Oncol; 2009 Dec; 11(6):757-66. PubMed ID: 19264916 [TBL] [Abstract][Full Text] [Related]
12. B7-homolog 1 expression by human glioma: a new mechanism of immune evasion. Wilmotte R; Burkhardt K; Kindler V; Belkouch MC; Dussex G; Tribolet Nd; Walker PR; Dietrich PY Neuroreport; 2005 Jul; 16(10):1081-5. PubMed ID: 15973152 [TBL] [Abstract][Full Text] [Related]
13. In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors. Berthon C; Driss V; Liu J; Kuranda K; Leleu X; Jouy N; Hetuin D; Quesnel B Cancer Immunol Immunother; 2010 Dec; 59(12):1839-49. PubMed ID: 20814675 [TBL] [Abstract][Full Text] [Related]
14. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Wu K; Kryczek I; Chen L; Zou W; Welling TH Cancer Res; 2009 Oct; 69(20):8067-75. PubMed ID: 19826049 [TBL] [Abstract][Full Text] [Related]
15. PI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma. Oh T; Ivan ME; Sun MZ; Safaee M; Fakurnejad S; Clark AJ; Sayegh ET; Bloch O; Parsa AT Immunotherapy; 2014; 6(6):737-53. PubMed ID: 25186604 [TBL] [Abstract][Full Text] [Related]
16. Anti-Tumor Effects of Sodium Meta-Arsenite in Glioblastoma Cells with Higher Akt Activities. Lee EJ; Sung JY; Koo KH; Park JB; Kim DH; Shim J; Lee CH; Park J; Kim YN Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256086 [TBL] [Abstract][Full Text] [Related]
17. Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function. Crane C; Panner A; Pieper RO; Arbiser J; Parsa AT J Immunother; 2009; 32(6):585-92. PubMed ID: 19483651 [TBL] [Abstract][Full Text] [Related]
18. Neddylation inhibition upregulates PD-L1 expression and enhances the efficacy of immune checkpoint blockade in glioblastoma. Zhou S; Zhao X; Yang Z; Yang R; Chen C; Zhao K; Wang W; Ma Y; Zhang Q; Wang X Int J Cancer; 2019 Aug; 145(3):763-774. PubMed ID: 31044422 [TBL] [Abstract][Full Text] [Related]
19. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells. Zhang R; Banik NL; Ray SK Cancer Chemother Pharmacol; 2008 Aug; 62(3):407-16. PubMed ID: 17960384 [TBL] [Abstract][Full Text] [Related]